Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.
The growth of the global longum market is driven by increase in demand for probiotic dietary supplements with probiotic ingredients and surge in awareness towards healthy food products. Furthermore, rise in disposable income allows consumers to purchase healthy alternatives to regular food products, which is expected to fuel the growth of the market. However, low level of awareness and meagre purchasing power in underdeveloped countries are anticipated to hinder the market growth.
The global market for Longum was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Longum was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Longum was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Longum was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Longum include ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA and Deerland Enzymes Inc, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Longum, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Longum by region & country, by Type, and by Application.
The Longum market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Longum.
麻豆原创 Segmentation
By Company
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc
Segment by Type:
0.2g/Piece
0.25g/Piece
Segment by Application
Medicine
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Longum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Longum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Longum in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Longum Product Introduction
1.2 Global Longum 麻豆原创 Size Forecast
1.2.1 Global Longum Sales Value (2019-2030)
1.2.2 Global Longum Sales Volume (2019-2030)
1.2.3 Global Longum Sales Price (2019-2030)
1.3 Longum 麻豆原创 Trends & Drivers
1.3.1 Longum Industry Trends
1.3.2 Longum 麻豆原创 Drivers & Opportunity
1.3.3 Longum 麻豆原创 Challenges
1.3.4 Longum 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Longum Players Revenue Ranking (2023)
2.2 Global Longum Revenue by Company (2019-2024)
2.3 Global Longum Players Sales Volume Ranking (2023)
2.4 Global Longum Sales Volume by Company Players (2019-2024)
2.5 Global Longum Average Price by Company (2019-2024)
2.6 Key Manufacturers Longum Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Longum Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Longum
2.9 Longum 麻豆原创 Competitive Analysis
2.9.1 Longum 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Longum Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Longum as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.2g/Piece
3.1.2 0.25g/Piece
3.2 Global Longum Sales Value by Type
3.2.1 Global Longum Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Longum Sales Value, by Type (2019-2030)
3.2.3 Global Longum Sales Value, by Type (%) (2019-2030)
3.3 Global Longum Sales Volume by Type
3.3.1 Global Longum Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Longum Sales Volume, by Type (2019-2030)
3.3.3 Global Longum Sales Volume, by Type (%) (2019-2030)
3.4 Global Longum Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Others
4.2 Global Longum Sales Value by Application
4.2.1 Global Longum Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Longum Sales Value, by Application (2019-2030)
4.2.3 Global Longum Sales Value, by Application (%) (2019-2030)
4.3 Global Longum Sales Volume by Application
4.3.1 Global Longum Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Longum Sales Volume, by Application (2019-2030)
4.3.3 Global Longum Sales Volume, by Application (%) (2019-2030)
4.4 Global Longum Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Longum Sales Value by Region
5.1.1 Global Longum Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Longum Sales Value by Region (2019-2024)
5.1.3 Global Longum Sales Value by Region (2025-2030)
5.1.4 Global Longum Sales Value by Region (%), (2019-2030)
5.2 Global Longum Sales Volume by Region
5.2.1 Global Longum Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Longum Sales Volume by Region (2019-2024)
5.2.3 Global Longum Sales Volume by Region (2025-2030)
5.2.4 Global Longum Sales Volume by Region (%), (2019-2030)
5.3 Global Longum Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Longum Sales Value, 2019-2030
5.4.2 North America Longum Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Longum Sales Value, 2019-2030
5.5.2 Europe Longum Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Longum Sales Value, 2019-2030
5.6.2 Asia Pacific Longum Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Longum Sales Value, 2019-2030
5.7.2 South America Longum Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Longum Sales Value, 2019-2030
5.8.2 Middle East & Africa Longum Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Longum Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Longum Sales Value
6.2.1 Key Countries/Regions Longum Sales Value, 2019-2030
6.2.2 Key Countries/Regions Longum Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Longum Sales Value, 2019-2030
6.3.2 United States Longum Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Longum Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Longum Sales Value, 2019-2030
6.4.2 Europe Longum Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Longum Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Longum Sales Value, 2019-2030
6.5.2 China Longum Sales Value by Type (%), 2023 VS 2030
6.5.3 China Longum Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Longum Sales Value, 2019-2030
6.6.2 Japan Longum Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Longum Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Longum Sales Value, 2019-2030
6.7.2 South Korea Longum Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Longum Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Longum Sales Value, 2019-2030
6.8.2 Southeast Asia Longum Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Longum Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Longum Sales Value, 2019-2030
6.9.2 India Longum Sales Value by Type (%), 2023 VS 2030
6.9.3 India Longum Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 ATCC Inc
7.1.1 ATCC Inc Company Information
7.1.2 ATCC Inc Introduction and Business Overview
7.1.3 ATCC Inc Longum Sales, Revenue and Gross Margin (2019-2024)
7.1.4 ATCC Inc Longum Product Offerings
7.1.5 ATCC Inc Recent Development
7.2 BioGaia AB
7.2.1 BioGaia AB Company Information
7.2.2 BioGaia AB Introduction and Business Overview
7.2.3 BioGaia AB Longum Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BioGaia AB Longum Product Offerings
7.2.5 BioGaia AB Recent Development
7.3 Mystic Pharmaceuticals Inc
7.3.1 Mystic Pharmaceuticals Inc Company Information
7.3.2 Mystic Pharmaceuticals Inc Introduction and Business Overview
7.3.3 Mystic Pharmaceuticals Inc Longum Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Mystic Pharmaceuticals Inc Longum Product Offerings
7.3.5 Mystic Pharmaceuticals Inc Recent Development
7.4 Hanson Ltd
7.4.1 Hanson Ltd Company Information
7.4.2 Hanson Ltd Introduction and Business Overview
7.4.3 Hanson Ltd Longum Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Hanson Ltd Longum Product Offerings
7.4.5 Hanson Ltd Recent Development
7.5 Biofodan A/S
7.5.1 Biofodan A/S Company Information
7.5.2 Biofodan A/S Introduction and Business Overview
7.5.3 Biofodan A/S Longum Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biofodan A/S Longum Product Offerings
7.5.5 Biofodan A/S Recent Development
7.6 BioCare Copenhagen ApS
7.6.1 BioCare Copenhagen ApS Company Information
7.6.2 BioCare Copenhagen ApS Introduction and Business Overview
7.6.3 BioCare Copenhagen ApS Longum Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BioCare Copenhagen ApS Longum Product Offerings
7.6.5 BioCare Copenhagen ApS Recent Development
7.7 Danisco A/S
7.7.1 Danisco A/S Company Information
7.7.2 Danisco A/S Introduction and Business Overview
7.7.3 Danisco A/S Longum Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Danisco A/S Longum Product Offerings
7.7.5 Danisco A/S Recent Development
7.8 Danone SA
7.8.1 Danone SA Company Information
7.8.2 Danone SA Introduction and Business Overview
7.8.3 Danone SA Longum Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Danone SA Longum Product Offerings
7.8.5 Danone SA Recent Development
7.9 Deerland Enzymes Inc
7.9.1 Deerland Enzymes Inc Company Information
7.9.2 Deerland Enzymes Inc Introduction and Business Overview
7.9.3 Deerland Enzymes Inc Longum Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Deerland Enzymes Inc Longum Product Offerings
7.9.5 Deerland Enzymes Inc Recent Development
8 Industry Chain Analysis
8.1 Longum Industrial Chain
8.2 Longum Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Longum Sales Model
8.5.2 Sales Channel
8.5.3 Longum Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
ATCC Inc
BioGaia AB
Mystic Pharmaceuticals Inc
Hanson Ltd
Biofodan A/S
BioCare Copenhagen ApS
Danisco A/S
Danone SA
Deerland Enzymes Inc
听
听
*If Applicable.